Actively Recruiting
Pencil Beam Proton Therapy for Pelvic Recurrences in Rectal Cancer Patients Previously Treated With Radiotherapy
Led by University of Aarhus · Updated on 2021-01-05
65
Participants Needed
1
Research Sites
420 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Study design: A prospective phase II, non-randomized observational study of dose-escalated pencil beam proton therapy re-irradiation for pelvic recurrences from rectal cancer. Re-irradiation is either a part of neo-adjuvant treatment or as a definitive treatment strategy for un-resectable recurrences.
CONDITIONS
Official Title
Pencil Beam Proton Therapy for Pelvic Recurrences in Rectal Cancer Patients Previously Treated With Radiotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Locally recurrent rectal cancer confirmed by biopsy as adenocarcinoma
- Available radiation dose plan from prior pelvic radiotherapy
- Previous pelvic radiotherapy with dose greater than 30 Gy EQD2
- Evaluated in multidisciplinary team conferences (Herlev, Aarhus)
- Age greater than 18 years
- Performance status 0 to 2
- Adequate organ function
- Provided informed consent
You will not qualify if you...
- Presence of non-resectable distant metastases detected by PET-CT
- Unable to undergo MRI or PET-CT scans
- Unable to attend full course radiotherapy and outpatient follow-up visits
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Danish Centre for Particle Therapy
Aarhus, Denmark, 8200
Actively Recruiting
Research Team
C
Camilla Kronborg, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here